Most large DNA viruses, like herpesviruses, encode anti-apoptotic proteins to interfere with the apoptotic cellular response to infection. Previous studies have shown that the US3 protein kinase of herpes simplex virus, in contrast to US3 of bovine herpes virus 1, is very potent in protecting cells from apoptosis induced by the virus itself or by a broad range of exogenous apoptotic stimuli. Here, we demonstrate that US3 of the swine alphaherpesvirus pseudorabies virus (PRV) suppresses PRV-induced apoptosis in swine-testicle (ST) cells at late stages in infection, and that it protects ST cells from apoptosis induced by either sorbitol or staurosporine. Interestingly, PRV US3 encodes a short and a long isoform, the latter of which contains a functional mitochondrial localization sequence. Transient transfections showed that the PRV US3 long isoform is more efficient in protecting ST cells from PRV-or staurosporine-induced apoptosis, suggesting a potential advantage for the mitochondrial localization of PRV US3 in implementing its anti-apoptotic function.
Introduction
During infection of a cell, most viruses generate proapoptotic signals that enable the host to limit virus replication and spread. Many viruses, especially large DNA viruses with a complicated and time-consuming replication cycle, have evolved various strategies to escape clearance by apoptosis of the infected cell. Indeed, poxviruses, adenoviruses and herpesviruses encode multiple anti-apoptotic genes to suppress apoptosis (reviewed by Koyama et al., 2000) . Over the last few years, several anti-apoptotic genes have been identified in both herpes simplex virus serotypes (HSV-1 and HSV-2). The US3 protein kinase, which is conserved among all a-herpesviruses including the swine pseudorabies virus (PRV) and the bovine herpesvirus type 1 (BHV-1), appears to be one of the most potent anti-apoptotic HSVencoded proteins. HSV US3 has been reported to counteract apoptosis triggered by virus infection, the overexpression of a variety of Bcl-2 family members, CD8 + T cells or various exogenous inducers such as osmotic shock, UV irradiation and Fas ligand (Asano et al., 2000; Cartier et al., 2003a,b; Hata et al., 1999; Jerome et al., 1999; Leopardi et al., 1997; Murata et al., 2002; Ogg et al., 2004) . In spite of the US3 conservation on a genetic level between all a-herpesviruses, no anti-apoptotic activity could be attributed to the US3 protein of BHV-1 (Takashima et al., 1999) .
Interestingly, and unlike HSV and BHV-1, PRV encodes for two US3 isoforms, an abundant short isoform (N95% of the US3 protein in infected cells) of 41 kDa and a long isoform (b5% of US3 protein in infected cells) of 53 kDa (van Zijl et al., 1990) . We recently found that both PRV US3 isoforms only differ by the presence of an operational 51 amino acid N-terminally located mitochondrial localization sequence in the US3 long isoform, which is absent in the US3 short isoform (Van Minnebruggen et al., 2003) . Regarding the pivotal role of mitochondria in apoptosis (Desagher and Martinou, 2000) , this mitochondrial localization of the long PRV US3 isoform may not be coincidental.
Although it has recently been shown that overexpression of the short PRV US3 isoform suppresses apoptosis induced by overexpression of the Bcl-2 family member Bax (Ogg et al., 2004) , nothing is known about the anti-apoptotic properties of the long isoform of PRV-US3. Further, it is not known whether PRV US3 has a role in protecting cells from apoptosis during infection or exogenous apoptotic stimuli. The aims of the current study were therefore (i) to investigate whether PRV US3 protects cells from apoptosis during infection or induced by exogenous inducers like sorbitol and staurosporine, and, if so, (ii) whether there is a difference between the long and the short US3 isoform with this respect.
Results

PRV US3 expression suppresses virus-induced apoptosis
The induction of apoptosis is nowadays recognized as a general cellular response to virus infection, limiting virus replication and spread (Koyama et al., 2000) . In this context, it has been shown that different members of the aherpesvirus family including HSV-1, HSV-2, BHV-1, and PRV (Aleman et al., 2001; Koyama et al., 1998; Leopardi et al., 1997; Takashima et al., 1999) trigger apoptosis during infection. For both HSV serotypes, it was demonstrated that the US3 protein kinase is able to suppress this virus-induced apoptosis (Hata et al., 1999; Leopardi et al., 1997) , whereas no such anti-apoptotic activity could be attributed to BHV-1 US3 (Takashima et al., 1999) .
To determine whether the US3 orthologue of PRV protects cells from apoptosis during PRV infection, swine testicle (ST) cells were either mock-infected or infected with wild-type PRV (NiA3 WT), an isogenic US3 deletion mutant (NiA3 US3 null) or an isogenic US3 rescue strain (NiA3 US3 R) at an moi of 10. At 6, 12, 18, and 24 h postinoculation (hpi), cells were collected and processed for the detection of apoptotic-specific fragmented DNA using the TUNEL reaction or for the detection of active caspase-3, the latter of which has been suggested to be one of the most reliable markers for apoptosis (van Cruchten and van Den Broeck, 2002) . Fig. 1A shows a slight increase in caspase-3 activation in ST cells infected with NiA3 WT at 18 and 24 hpi compared to mock-infected ST cells (4.2 F 1.6% and 4.5 F 0.2% to 1.4 F 0.2%, respectively), indicating that ST cells infected with wild-type PRV undergo apoptotic cell death to a limited extent at late stages in infection (z18 hpi). Infection of ST cells with NiA3 US3 null, however, resulted in a slight increase in the percentage of active caspase-3-positive cells at 18 hpi and in a strong increase in active caspase-3-positive cells at 24 hpi compared to wild-type PRV-infected cells. At 24 hpi, 42.1 F 2.0% of the NiA3 US3 null-infected ST cells were positive for active caspase-3 compared to 4.5 F 0.2% and 4.6 F 0.5% active caspase-3-positive cells after infection with NiA3 wild type or US3 rescue strain, respectively. Similar results were obtained using the TUNEL assay (Fig. 1B) . Deletion of US3 from the wildtype NiA3 strain resulted in a slight increase in the number of TUNEL-positive cells at 12 and 18 hpi compared to the percentage of TUNEL-positive cells after infection with the wild type or rescue strain. However, this increase became very prominent at 24 hpi where deletion of US3 resulted in 39.1 F 3.1% TUNEL-positive cells compared to 5.7 F Fig. 1 . PRV US3 protects ST cells from PRV-induced apoptosis at late stages in infection. ST cells were mock-infected (white column) or inoculated with NiA3 WT (light gray column), NiA3 US3 null (dark gray columns), or NiA3 US3 Rescue (black column) at an moi of 10. At 6, 12, 18, and 24 hpi, the percentage of apoptotic cells was determined either by visualizing active caspase-3 (A) or by TUNEL assay (B). Columns represent the mean, and error bars the standard deviation of triplicate assays.
3.2% and 6.4 F 0.5% TUNEL-positive cells after infection with the wild type or rescue strain, respectively.
Together, these results indicate that the PRV US3 protein kinase is of critical importance to protect cells from apoptotic cell death at late stages in infection.
PRV US3 protein kinase blocks apoptosis induced by sorbitol and staurosporine HSV-1 and HSV-2 are known to inhibit apoptosis induced by exogenous stimuli like sorbitol or stauroporine and US3 is an important anti-apoptotic protein in these processes (Aubert et al., 1999; Cartier et al., 2003b; Hata et al., 1999; Murata et al., 2002) . In contrast, BHV-1 US3 has been shown not to be able to inhibit sorbitol-induced apoptosis (Takashima et al., 1999) . Here, we investigated whether PRV infection protects cells from apoptosis induced by sorbitol or stauroporine, and, if so, whether this requires the presence of US3. It has been demonstrated that incubation of cells with high concentrations of sorbitol induces apoptosis by altering the structure of the plasma membrane thereby clustering cell surface receptors and activating their signal transduction cascade (Rosette and Karin, 1996) , while staurosporine, a protein kinase C inhibitor, is known to induce apoptosis in a caspase-3-dependent manner through a mitochondrial-related mechanism (Jacobsen et al., 1996; Khan et al., 2000) .
In brief, ST cells were either mock infected or infected with NiA3 WT, NiA3 US3 null, or NiA3 US3 R at an moi of 10. At 5 hpi, when there is an abundant expression of US3 (Van Minnebruggen et al., 2003) , apoptosis was induced with sorbitol or staurosporine as described in Materials and methods or cells were left untreated. Caspase-3 activation was monitored at 3 h post treatment (sorbitol), corresponding to 8 hpi and at 12 h post treatment (staurosporine), corresponding to 17 hpi. Since no apparent differences could be observed in the number of apoptotic cells detected with the TUNEL assay or active caspase-3 staining in the former experiment and since activated caspase-3 is the more reliable method of the two (van Cruchten and van Den Broeck, 2002) , the number of apoptotic cells in the experiments presented here were determined by staining of activated caspase-3. Fig. 2 shows relative percentages of apoptosis, compared to mock-infected cells treated with sorbitol (set to 100% in Fig. 2A ) or staurosporine (set to 100% in Fig.  2B ). Mock-infected cells that were not treated with sorbitol or staurosporine showed much less apoptosis (relative percentages of 20.6 F 1.6% and 14.7 F 6.6%, respectively). Caspase-3 activation in sorbitol-or staurosporinetreated ST cells that were infected with NiA3 WT was similar as in nontreated mock-infected cells (relative percentages of 29.8 F 4.0% and 19.8 F 6.0%, respectively), which indicates that PRV infection protects cells from sorbitol-and staurosporine-induced apoptosis. Cells inoculated with the NiA3 US3 null virus were not able to withstand induction of apoptosis by either sorbitol or staurosporine and the relative percentages of active caspase-3-positive cells (109.8 F 4.9% and 115.8 F 16.9%, respectively) was comparable as in sorbitol-or staurosporine-treated mock-infected cells. NiA3 US3 Rinfected ST cells showed a resistance to sorbitol-and staurosporine-induced apoptosis that was comparable to the resistance observed in NiA3 WT-infected cells.
Overall, these results show that PRV infection of cells renders these cells resistant to apoptosis induced by either sorbitol or staurosporine and that expression of PRV US3 is absolutely required for this resistance. 
PRV US3 on itself protects cells from apoptosis with a key role for the long isoform
The objective of the US3 transient transfection assays performed in this part of the study was twofold. First, it was investigated whether PRV US3 can restore the antiapoptotic activity in trans in NiA3 US3 null-infected cells and whether PRV US3 on its own, in the absence of other viral proteins, can protect cells from staurosporine-induced apoptosis. Secondly, given that PRV encodes for two US3 isoforms, an abundant short isoform of 41 kDa and a long isoform of 53 kDa containing a mitochondrial localization sequence (Van Minnebruggen et al., 2003) , we wanted to investigate whether these two isoforms show a difference in protecting cells from apoptosis induced by NiA3 US3 null infection or staurosporine.
Therefore, ST cells were transiently transfected with either the control plasmid encoding LacZ (pLacZ), pKG1, encoding the PRV NiA3 US3 long isoform, or pKG2, encoding the PRV NiA3 US3 short isoform. At 24 h post transfection, apoptosis was induced either by infection with NiA3 US3 null for 24 h (Fig. 3A) or by addition of 1.5 AM staurosporine for 12 h (Fig. 3B) . For both experiments, transfected cells were visualized using anti-V5 (pLacZ) or anti-US3 (pKG1 and pKG2) antibodies, whereas apoptotic cells were identified with anti-active caspase-3 antibodies or a TUNEL assay.
The white columns in Fig. 3A show the percentages of active caspase-3-positive cells, relative to the percentage obtained in pLacZ-transfected cells that were infected with NiA3 US3 null (relative value set to 100%). Infection with NiA3 WT instead of NiA3 US3 null led to a decrease in the relative percentage of active caspase-3-positive transfected cells to approximately 60% (P b 0.01, Student's t test), indicating once more that the presence of PRV US3 has a protective effect towards PRV-induced apoptosis. The transfection assay on itself had a pro-apoptotic effect since higher relative percentages of active caspase-3-positive cells were observed in pLacZ-transfected NiA3 WT-infected cells (60.4 F 3.8%, see Fig. 3A ) compared to nontransfected, NiA3 WT-infected cells (25.1%, data not shown). Cells that were transfected with the US3 short isoform (pKG2) and subsequently infected with NiA3 US3 null showed a significant reduction in relative percentage of active caspase-3-positve cells to 77.5% compared to cells transfected with pLacZ (100%) (P b 0.05, Student's t test). Cells that were transfected with the long isoform (pKG1) showed a much stronger protection against apoptosis induced by NiA3 US3 null (relative percentage of apoptosis of 49.7%) (P b 0.01, Student's t test). An analogous experiment was performed, but now using the TUNEL assay for analyzing the relative percentage of apoptotic cells (gray columns in Fig.  3A ). This experiment gave similar results compared to the analysis of apoptosis with anti-active caspase-3 antibodies. Transfection with pKG1, but not pKG2, and subsequent infection with US3 null virus resulted in co-localization between US3 and mitochondria, indicating that the transfected long US3 isoform not only targets to mitochondria in noninfected cells (Van Minnebruggen et al., 2003) , but also in an infection background (data not shown).
Similar results were obtained using staurosporine to induce apoptosis and are shown in Fig. 3B . Percentages given are again relative values: the number of apoptotic cells as detected by anti-active caspase-3 antibodies (white columns) or by the TUNEL assay (gray columns) in staurosporine-treated cells that were transfected with a control plasmid (pLacZ) was set to 100%. Again, cells transfected with the US3 short isoform (pKG2) prior to treatment with staurosporine were able to reduce caspase-3 activation to some extent compared to cells transfected with the control plasmid LacZ (80.6 F 4.5% and 100%, Fig. 3 . Transfection of the long, and, to a lesser extent, the short US3 isoform restores anti-apoptotic activity in trans in NiA3 US3 null-infected ST cells, and protects transfected cells from staurosporine-induced apoptosis. ST cells were transiently transfected either with a control plasmid, pLacZ, or the plasmids pKG1 (PRV US3 long isoform) or pKG2 (PRV US3 short isoform). At 24 h post transfection, cells were inoculated with NiA3 WT or NiA3 US3 null at an moi of 10 for 24 h (A) or cells were left untreated (NT) or treated with 1.5 AM staurosporine for 12 h to induce apoptosis (B). Afterwards, transfected cells were visualized with anti-V5 antibodies (pLacZ) or anti-US3 antibodies (pKG1 and pKG2) and apoptotic cells were visualized by anti-active caspase-3 antibodies (white columns) or TUNEL assay (gray columns). Relative percentages are given based on the number of apoptotic cells in pLacZ-transfected cells infected with NiA3 US3 null (A) or treated with staurosporine (B) (each set to 100%). Columns represent the mean, and error bars the standard deviation of triplicate assays. respectively) (P b 0.01, Student's t test). Nevertheless, only cells transfected with the US3 long isoform (pKG1) were able to reduce levels of staurosporine-induced caspase-3 activation to (below) the level of nontreated pLacZtransfected cells (50.0 F 0.4% and 57.5 F 4.5%, respectively; P b 0.01, Student's t test). Again, analogous results were acquired using the TUNEL assay (gray columns in Fig. 3B ). The expression level of US3 was similar in cells transfected with either the US3 long or the US3 short isoform, indicating that the stronger antiapoptotic effect of US3 in cells transfected with the long US3 isoform versus cells transfected with the US3 short isoform was not due to differences in expression level (data not shown).
Together, these results clearly indicate that transient transfection of PRV US3 can restore the anti-apoptotic activity in trans in NiA3 US3 null-infected cells and that US3 on its own, in the absence of other viral proteins, possesses anti-apoptotic activity since transfection protects cells from staurosporine-induced apoptosis. Additionally, the PRV US3 long isoform displays more robust potency in protecting cells from apoptosis induced by PRV or staurosporine compared to its short isoform, thereby suggesting the potential importance of the mitochondrial localization of PRV US3 in implementing its anti-apoptotic function.
Discussion
Expression of anti-apoptotic proteins by large DNA viruses like herpesviruses is a prerequisite to counteract the pro-apoptotic triggers during infection that enable the host to limit virus replication and spread. In the current study, it was our goal to investigate the potential anti-apoptotic function of the US3 protein kinase of the porcine aherpesvirus pseudorabies virus (PRV). We demonstrated that infection of swine testicle (ST) cells with wild-type PRV leads to a limited extent of apoptotic cell death at late stages in infection, but that infection with a US3 null virus results in extreme apoptotic cell death at 24 hpi (Figs.  1A,B) . The observation that a US3 null virus only causes extensive apoptotic cell death at late stages in infection, may suggest that, besides US3, other viral proteins may be involved in anti-apoptotic activities earlier in infection. Indeed, for HSV, in addition to US3, several other viralencoded proteins have been suggested to display antiapoptotic characteristics that may act at early stages in infection, such as HSV-1 ICP4, ICP27, ICP22, US5, US6 (reviewed by Aubert and Blaho, 2001 ), ICP34.5 (Chou and Roizman, 1992) , and HSV-2 ICP10 (Perkins et al., 2002) . Further, we also demonstrated that PRV US3 is able to suppress apoptosis induced by exogenous stimuli like sorbitol and staurosporine. Interestingly, although the US3 gene is conserved among all members of the a-herpesviruses, its anti-apoptotic function does not seem to be equally well conserved. It has been demonstrated that herpes simplex virus (HSV) US3 is necessary for the inhibition of apoptosis in infected cells and in cells subjected to different apoptotic stimuli (Asano et al., 2000; Cartier et al., 2003a,b; Hata et al., 1999; Jerome et al., 1999; Leopardi et al., 1997; Murata et al., 2002; Ogg et al., 2004) . On the other hand, Takashima et al. (1999) demonstrated that the bovine herpesvirus type 1 (BHV-1) US3 protein kinase does not seem to possess anti-apoptotic properties and, consequently, is not involved in protecting cells from apoptotic cell death during BHV-1 infection.
The PRV US3 gene, unlike its HSV and BHV-1 orthologues, encodes two isoforms: a short US3 isoforms that localizes to the nucleus and diffusely to the cytoplasm, and a long US3 isoform that contains a mitochondrial localization sequence (MLS) that targets its predominantly to mitochondria (Calton et al., 2004 , Van Minnebruggen et al., 2003 . A recent report by Ogg et al. (2004) showed that the short isoform of PRV US3 possesses anti-apoptotic properties in Bax-overexpressing cells. However, these authors did not explore the potential anti-apoptotic properties of the long US3 isoform. By performing transfection experiments using US3 expression vectors that encode either the long or short isoform, we showed that expression in trans of the PRV US3 short isoform can only partially restore the anti-apoptotic activity of US3 during virus infection and that this recombinant US3 short isoform can only partially protect cells from staurosporine-induced apoptosis. However, expression of the PRV US3 long isoform in trans completely restored the anti-apoptotic activity of US3 during virus infection and transfection of the long isoform protected cells much more potently against staurosporine-induced apoptosis than the short US3 isoform.
Based on these results, it is tempting to speculate that the predominant mitochondrial localization of the long US3 isoform may be beneficial for the anti-apoptotic activity of PRV US3. Although the mechanism how PRV US3 exerts its anti-apoptotic function is not yet known, and although HSV US3 has to data not been reported to contain a MLS, it is possible that PRV exerts its anti-apoptotic activity through similar mechanisms as HSV US3. Different hypotheses could then be given how the mitochondrial localization of PRV US3 may be advantageous, albeit not absolutely required, for its anti-apoptotic effect. Pro-apoptotic proteins that have thus far been shown to be targets for HSV US3-mediated interference such as Bid and Bad are known to travel from the cytoplasm to mitochondria to exert their proapoptotic effect (reviewed by Burlacu, 2003) . Hence, although the PRV US3 short isoform and HSV US3, which both have been shown to be present in the cytoplasm, may be able to interfere with the pro-apoptotic activity of these proteins (Benetti et al., 2003; Cartier et al., 2003a,b; Munger and Roizman, 2001; Ogg et al., 2004) , the chance of encountering these pro-apoptotic targets by US3 may increase significantly when it localizes to mitochondria. Alternatively, mitochondria-localized US3 may have access to a different or wider spectrum of target proteins to counteract apoptosis, thereby resulting in a more potent antiapoptotic effect. It will, therefore, be interesting to unravel the exact mechanism of the anti-apoptotic activity of PRV US3 and to find an answer on whether and how the difference in localization between the long and short US3 isoform results is the difference in efficiency of counteracting apoptosis that we observed here.
Materials and methods
Cells, virus strains, and inoculation
Cells
Swine testicle (ST) cells were cultured in ST culture medium [Eagle's minimal essential medium (MEM) supplemented with 10% fetal bovine serum (FBS), 100 U/ml penicillin, 0.1 mg/ml streptomycin, 0.1 mg/ml kanamycin, and 0.3 mg/ml glutamin].
Virus strains
Virulent pseudorabies virus wild-type strain NiA3 (NiA3 WT), NiA3 US3 deletion mutant (NiA3 US3 null), and NiA3 US3 rescue strain (NiA3 US3 R) were used and were described earlier (Baskerville et al., 1973; Kimman et al., 1992; van Zijl et al., 1990) . The PRV US3 null virus was constructed by insertion of a 20-mer oligonucleotide, containing TAG translational stop codons in all reading frames, in the 5Vpart of the US3 open reading frame.
Inoculation
ST cells were inoculated with either of the NiA3 strains at a multiplicity of infection of 10 TCID 50 in culture medium. After incubation for 1 h at 37 8C, the inoculum was aspirated and fresh culture medium was added.
Antibodies and reagents
US3-specific mouse monoclonal antibodies were generated at the Princeton University monoclonal antibody facility against a fusion protein consisting of the c-terminal 476 amino acids of US3 and GST, and purified using GSTagarose. Mouse monoclonal antibodies directed against V5 were purchased from Invitrogen (Groningen, The Netherlands). Rabbit polyclonal antibodies directed against active caspase-3 were obtained from R&D Systems Inc. (Minneapolis, MN, USA) and the secondary antibodies Texas Redconjugated goat anti-mouse IgG and FITC-conjugated goat anti-rabbit IgG were obtained from Molecular Probes (Eugene, OR, USA). DNA fragmentation was detected based on the TUNEL reaction using the In Situ Cell Death Detection Kit (Fluorescein) obtained from Roche (Mannheim, Germany). The apoptotic inducers D-sorbitol and staurosporine were purchased from Sigma Chemical Company (St. Louis, MO, USA).
Induction of apoptosis
Induction of apoptosis by osmotic shock was based on a previous report (Koyama and Miwa, 1997) . Cells were incubated with 3M D-Sorbitol in ST culture medium without FBS for 1 h. Cells were then washed twice in sorbitol-free medium and incubated further in ST culture medium for 2 h. For the induction of apoptosis with staurosporine, cells were washed twice in ST culture medium with 1% FBS and subsequently incubated with 1.5 AM staurosporine in ST culture medium with 1% FBS for 12 h.
Construction of expression vectors and transfection assay
The sequence encoding the US3 long isoform was PCRamplified from the DNA of PRV NiA3 WT strain with Platinum pfx DNA polymerase (Invitrogen) by use of the forward primer 5VCACCTGTGGGCCAGCGCGTAGTA3V and the reverse primer 5VCACTTCATTGTTGAGCTGTQ GGAGAT3V, in the presence of 4% dimethylsulfoxide (DMSO). The PCR reaction consisted of an initial 2 min, 30 s denaturation step at 94 8C, followed by 35 cycles of denaturation (94 8C, 45 s), annealing (59 8C, 45 s), and extension (68 8C, 1 min, 30 s), and a final 10-min extension step. The PCR-amplified US3 long isoform encoding sequence was cloned into the pcDNA3.1D/V5-HIS-TOPO vector following the manufacturer's instructions (Invitrogen) to create pKG1, encoding the long US3 isoform. Plasmid pKG2, encoding the short US3 isoform, was generated as follows: pKG1 was digested with HindIII and Eco47III, releasing a 229-bp fragment, blunt ended using T4 DNA polymerase (Invitrogen) and religated.
Next, plasmids pKG1, pKG2, or control plasmid pcDNA3.1D/V5-His/lacZ (pLacZ) (Invitrogen) were transiently transfected in ST cells grown to 90% confluence using Lipofectamine and Plus Reagent according to the manufacturer's instructions (Invitrogen). At 24 h post transfection, cells were either infected with NiA3 WT or NiA3 US3 null strain for 24 h or treated with 1.5 AM staurosporine for 12 h. Cells were collected and further processed for immunofluorescence staining.
Immunofluorescence staining procedures
All staining procedures were performed in suspension to prevent loss of apoptotic cells. Cells were detached using PBS without Ca 2+ and Mg 2+ containing 0.5 mM EDTA. After being washed in ice-cold PBS, cells were fixed with 3% paraformaldehyde for 10 min on ice followed by permeabilization with 0.2% Triton X-100 in RPMI-1640 (Gibco BRL, Life Technologies Inc., Gaitersburg, MD) for 3 min on ice. Antibodies, at all times incubated for 1 h at 37 8C, were always diluted in PBS: anti-US3 (1:80), antiactive caspase-3 (1:100), or anti-V5 (1:300) for primary antibody dilutions, and Texas Red-conjugated goat antimouse IgG (1:50) and FITC-conjugated goat anti-rabbit IgG (1:100) for secondary antibody dilutions. The detection of fragmented DNA with the TUNEL reaction was performed according to the manufacturer's instruction (Roche). All cells were counterstained using Hoechst (Molecular Probes) and mounted in a glycerin-PBS solution (0.9:0.1, vol/vol) with 2.5% 1,4-diazabicyclo(2.2.2)octane (Janssen Chemica, Beerse, Belgium) and analyzed by fluorescence microscopy.
For each experiment, 200 cells were scored. Each experiment was repeated three times and results are presented as mean (relative) percentages with corresponding standard deviations.
